Arcadia Biosciences (FRA:17D) Cyclically Adjusted Book per Share: €326.47 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:17D Arcadia Biosciences Inc FRA:17D
43 GF Score
Price €3.72
GF Value €18.87
! 4 Warning Signs
View Full Analysis

What is Arcadia Biosciences Cyclically Adjusted Book per Share?

Arcadia Biosciences FRA:17D 43 Cyclically Adjusted Book per Share is €326.47 as of Mar. 2026. GuruFocus rates FRA:17D with a GF Score™ of 43/100 and a GF Value™ of €18.87. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Arcadia Biosciences's adjusted book value per share for the three months ended in Mar. 2026 was €1.213. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €326.47 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Arcadia Biosciences's average Cyclically Adjusted Book Growth Rate was -44.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-14), Arcadia Biosciences's current stock price is €3.72. Arcadia Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €326.47. Arcadia Biosciences's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Arcadia Biosciences was 0.27. The lowest was 0.01. And the median was 0.03.


Arcadia Biosciences  (FRA:17D) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Arcadia Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.72/326.47
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Arcadia Biosciences was 0.27. The lowest was 0.01. And the median was 0.03.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Arcadia Biosciences Cyclically Adjusted Book per Share Related Terms


Arcadia Biosciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Arcadia Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arcadia Biosciences Cyclically Adjusted Book per Share Chart

Arcadia Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 37.50 147.21 264.46

Arcadia Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 275.42 165.71 178.09 264.46 326.47

FRA:17D vs ORISF, ARRT, CIMG: Cyclically Adjusted Book per Share Comparison

For the Packaged Foods subindustry, Arcadia Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcadia Biosciences Cyclically Adjusted PB Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Arcadia Biosciences's Cyclically Adjusted PB Ratio falls into.


FRA:17D
43GF Score
Arcadia Biosciences Inc FRA:17D
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arcadia Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arcadia Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.213/330.2130*330.2130
=1.213

Current CPI (Mar. 2026) = 330.2130.

Arcadia Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 506.291 241.018 693.657
201609 437.714 241.428 598.683
201612 375.786 241.432 513.973
201703 324.094 243.801 438.965
201706 247.868 244.955 334.140
201709 168.868 246.819 225.924
201712 127.660 246.524 170.998
201803 8.726 249.554 11.546
201806 58.479 251.989 76.632
201809 93.059 252.439 121.730
201812 94.655 251.233 124.412
201903 4.706 254.202 6.113
201906 46.707 256.143 60.213
201909 56.935 256.759 73.223
201912 32.106 256.974 41.256
202003 46.153 258.115 59.045
202006 42.880 257.797 54.925
202009 35.339 260.280 44.834
202012 67.827 260.474 85.987
202103 70.137 264.877 87.437
202106 62.384 271.696 75.820
202109 61.023 274.310 73.459
202112 49.580 278.802 58.723
202203 49.508 287.504 56.862
202206 45.692 296.311 50.920
202209 41.102 296.808 45.728
202212 32.232 296.797 35.861
202303 18.316 301.836 20.038
202306 14.884 305.109 16.109
202309 13.114 307.789 14.069
202312 9.163 306.746 9.864
202403 7.169 312.332 7.579
202406 7.977 314.175 8.384
202409 6.790 315.301 7.111
202412 4.354 315.605 4.556
202503 6.026 319.799 6.222
202506 2.875 322.561 2.943
202509 3.392 324.800 3.449
202512 2.575 324.054 2.624
202603 1.213 330.213 1.213

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €326.47 mean?
Arcadia Biosciences (FRA:17D) has a Cyclically Adjusted Book per Share of €326.47 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arcadia Biosciences and its competitors.
Is Arcadia Biosciences' Cyclically Adjusted Book per Share too high?
Arcadia Biosciences' current Cyclically Adjusted Book per Share is €326.47. Overall, Arcadia Biosciences has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' Cyclically Adjusted Book per Share compare to ORISF and ARRT?
Arcadia Biosciences' Cyclically Adjusted Book per Share of €326.47 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Book per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Arcadia Biosciences and its competitors. Arcadia Biosciences's current Cyclically Adjusted Book per Share is €326.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Arcadia Biosciences (FRA:17D) has a current Cyclically Adjusted Book per Share of €326.47. The stock's GF Value™ is €18.87, compared to a current price of €3.72 — trading 80.3% below its estimated fair value. The current Cyclically Adjusted Book per Share is €326.47. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Arcadia Biosciences (FRA:17D), the current Cyclically Adjusted Book per Share is €326.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arcadia Biosciences (FRA:17D) Overvalued in 2026?

Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued. The current stock price of €3.72 is trading 80.3% below its estimated GF Value™ of €18.87.

Key valuation signals for FRA:17D:

  • Cyclically Adjusted Book per Share: €326.47
  • GF Value™: €18.87 vs. price of €3.72 (80.3% below fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the FRA:17D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arcadia Biosciences Business Description

Other Exchanges RKDA:USA
Address 5950 Sherry Lane, Suite 2000, Dallas, TX, USA, 75225
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score

Get the complete analysis for FRA:17D

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.72
Price
€18.87
GF Value